公司资料
Veradigm 股价、新闻与催化剂
- 股票代码:
- MDRX
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
4.99 USD (+1.84%)
收盘价
最后更新: 2026年8月17日
—
市值
股价为何变动
The latest company update was “Veradigm to Participate in Two Upcoming Investor Conferences”. MDRX changed 1.84% and closed at $4.99 on Aug 17, 2026, indicating a relatively limited closing-price reaction to this company update.
公司概览
业务概览
Veradigm is a healthcare information and analytics company focused on software, data, and workflow tools for providers and life-sciences customers. Its business is more about information infrastructure than therapeutic innovation.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Veradigm sits in healthcare IT.
商业模式特征
Revenue depends on software subscriptions, data products, and the commercialization of workflow tools across healthcare users.
生物医药行业定位
Veradigm is outside biotech and belongs to the healthcare information layer, where software adoption and execution matter most.
未来催化剂
- Veradigm's catalysts are claims-data products, payer and life-science software demand, and any operating update that clarifies the turnaround path. The company is still a software-and-data execution story.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。